SOLACI symposium at EURO PCR 2017

The Latin American Society of Interventional Cardiology proudly joined the international meeting “Euro PCR 2017”, celebrated on May 16 to 19 in the city of Paris, France. During the event, a delegation of prominent professionals, headed by SOLACI Chair Dr. Ricardo Lluberas, presented a live case entitled “Complex Left Main PCI”.

 

The transmission took place in the large “Theatre Bleu”, at the luxurious Palais des Congrès, a prestigious convention center of the City of Light.

 

The aims of this session revolved around three key factors:

  1. Knowing when to treat a left main lesion with PIC (percutaneous coronary intervention).
  2. Knowing the fundamental technical aspects to perform a safe successful procedure.
  3. Discovering the use of intracoronary imaging.

SOLACI Symposium at EURO PCR 2017

The procedure was transmitted live from San Carlos Clinical University Hospital, in Madrid, Spain, and the operators were Drs. Javier Escaned and Antonio Fernández Ortiz. After the procedure, a general assessment was carried out, with the opportunity to reflect upon diverse matters, such as: the appropriate revascularization method, how to analyze lesions prior procedure, technical issues and outcome assessment.

 

The delegation was comprised by Drs. Andreas Baumbatch, Ricardo Lluberas, Mario Araya, Fernando Cura, Tian Hai Koh, José Luis Leiva Pons, Luis Nombela, Javierz Escaned, Antonio Fernández Ortiz, Ignacio Cruz González, Marta Kaluzna-Olesky and Ribeiro.

 

SOLACI is proud to have participated once more of one of the most relevant annual meetings of interventional cardiology in the world. We strongly believe in fostering the exchange of interesting and educational experiences within our area of expertise, to strengthen our network of colleagues throughout the world, promoting and expanding the Latin American practice towards new horizons.

 

See the complete live case  (prior registration).

 

Patient Characteristics

Caso-PCR-2017.ppt


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...